Why the study?
Growing evidence indicates that impaired fibrinolysis mediated by multiple complex mechanisms is involved in VTE, prompting an overview of available data linking fibrinolysis to VTE and its long-term sequelae.
Key points are not available for this paper at this time.
Design
Overview
Answers are grounded in this paper and cite their sources.
Clot lysis time may refine post-VTE recurrence risk models; leaves open whether fibrinolysis is a modifiable therapeutic target.
Fibrinolysis is of paramount importance in maintaining or regaining the patency of veins and pulmonary arteries obstructed by thrombi. Growing experimental and clinical evidence indicates that impaired fibrinolysis mediated by multiple complex mechanisms is involved in venous thromboembolism (VTE). Global plasma fibrin clot lysis markers, especially clot lysis time, have been reported to predict recurrent deep-vein thrombosis and pulmonary embolism. The current overview summarizes available data linking fibrinolysis to VTE and its long-term sequelae.
No takes yet. Share an insight, caveat, or question.
Anetta Undas (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: